So, which is it?

Our friends at CURP and A Better City held an event on Oct. 31st to promote a new study that advocated for additional transit spending to aid the biotech industry in Boston and Cambridge.

But this Sunday’s Globe reports that biotech firms are moving to the less costly suburbs.

Which suggests that additional transit spending is not required to aid this industry.